KA
ADMS

Kerrisdale Advisers’s Adamas Pharmaceuticals ADMS Stock Holding History

Kerrisdale Advisers’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-229,347
Closed -$1.17M – 45
2019
Q3 		$1.17M Hold
229,347
– – 0.76% 22
2019
Q2 		$1.42M Buy
229,347
+160,500
+233% +$923K 0.51% 21
2019
Q1 		$490K Hold
68,847
– – 0.2% 30
2018
Q4 		$588K Sell
68,847
-3,993
-5% -$51.9K 0.36% 21
2018
Q3 		$1.46M Hold
72,840
– – 1.43% 10
2018
Q2 		$1.88M Sell
72,840
-262,701
-78% -$7.27M 0.78% 8
2018
Q1 		$8.02M Buy
335,541
+254,256
+313% +$8.02M 5.58% 7
2017
Q4 		$2.75M Sell
81,285
-682,642
-89% -$19.1M 5.58% 3
2017
Q3 		$16.2M Buy
+763,927
New +$14M 16.88% 2

Other funds holding ADMS

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return